THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.
复制标题

DOI:
10.7150/thno.3645
复制
发表时间:
2012
期刊:
影响因子:
12.4
通讯作者:
Kulkarni HR
Kulkarni HR
中科院分区:
医学1区
文献类型:
--
作者:
Baum RP;Kulkarni HR

文献摘要

参考文献

被引文献

相似文献

首字母缩写Theranostics集中体现了诊断和治疗的不可分离性,这是医学的支柱,并考虑到针对特定患者的疾病个性化管理。肿瘤的分子表型可以通过使用正电子发射断层扫描(PET)、单光子发射计算机断层扫描(SPECT)、磁共振成像(MRI)或光学方法的特定探针的分子成像来确定,以便针对肿瘤及其环境进行特定的靶向治疗。为了满足这些需求,我们需要确定靶点、配体、偶联和标记化学、最合适的放射性核素、生物分布调节剂,并最终选择合适的患者进行个性化治疗。使用Ga-68标记的示踪剂与正电子发射断层扫描/计算机断层扫描(PET/CT)诊断神经内分泌肿瘤(Net),以及使用Lu-177或其他金属放射性核素进行放射性核素治疗的理论证明,个性化放射性核素治疗在今天已经是事实,而不是虚构的。
The acronym THERANOSTICS epitomizes the inseparability of diagnosis and therapy, the pillars of medicine and takes into account personalized management of disease for a specific patient. Molecular phenotypes of neoplasms can be determined by molecular imaging with specific probes using positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), or optical methods, so that the treatment is specifically targeted against the tumor and its environment. To meet these demands, we need to define the targets, ligands, coupling and labeling chemistry, the most appropriate radionuclides, biodistribution modifiers, and finally select the right patients for the personalized treatment. THERANOSTICS of neuroendocrine tumors (NETs) using Ga-68 labeled tracers for diagnostics with positron emission tomography/ computed tomography (PET/CT), and using Lu-177 or other metallic radionuclides for radionuclide therapy by applying the same peptide proves that personalized radionuclide therapy today is already a fact and not a fiction.
DOI: 10.3748/wjg.15.5867
发表时间: 2009-12-14
影响因子: 4.3
作者:
Kaemmerer, Daniel;Prasad, Vikas;Baum, Richard P.
通讯作者: Baum, Richard P.
DOI: 10.1007/s00259-007-0450-1
发表时间: 2007-10-01
影响因子: 9.1
作者:
Buchmann, I.;Henze, M.;Haberkorn, U.
通讯作者: Haberkorn, U.
DOI: 10.2967/jnumed.109.071712
发表时间: 2010-05-01
影响因子: 9.3
作者:
Ambrosini, Valentina;Campana, Davide;Fanti, Stefano
通讯作者: Fanti, Stefano
DOI: 10.1200/jco.2007.15.2553
发表时间: 2008-05-01
影响因子: 45.3
作者:
Kwekkeboom, Dik J.;de Herder, Wouter W.;Krenning, Eric P.
通讯作者: Krenning, Eric P.
DOI: 10.1007/s00259-011-1846-5
发表时间: 2011-09-01
影响因子: 9.1
作者:
Kaemmerer, Daniel;Peter, Luisa;Baum, Richard Paul
通讯作者: Baum, Richard Paul